Celea Therapeutics News and Activities

Acquisition, funding and merger involving Celea Therapeutics.

• Celea Therapeutics has just announced a $180 Million fundraising (posted on July 6 2026).

View the org chart displaying its 0 main executives

Most searched biographies at Celea Therapeutics

Create your alert
to follow the executive moves at Celea Therapeutics.

Celea Therapeutics has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Celea Therapeutics has just announced a $180 Million fundraising (posted on July 6 2026).
• Novartis has announced the acquisition of Myricx Bio  (posted on July 6 2026).
• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Celea Therapeutics

Social media about Celea Therapeutics

• Celea Therapeutics on Wikipedia, Google News & Yahoo Finance
• Celea Therapeutics on LinkedIn, X (Twitter) & YouTube